Page 96 - Read Online

Gupta et al. Extracell Vesicles Circ Nucleic Acids 2023;4:170-90 https://dx.doi.org/10.20517/evcna.2023.12 Page 190

therapy. Biomaterials 2014;35:2383-90. DOI
188. Bai J, Duan J, Liu R, et al. Engineered targeting tLyp-1 exosomes as gene therapy vectors for efficient delivery of siRNA into lung
cancer cells. Asian J Pharm Sci 2020;15:461-71. DOI PubMed PMC
189. Liang Y, Xu X, Li X, et al. Chondrocyte-targeted microRNA delivery by engineered exosomes toward a cell-free osteoarthritis
therapy. ACS Appl Mater Interfaces 2020;12:36938-47. DOI
190. Choi H, Choi K, Kim DH, et al. Strategies for targeted delivery of exosomes to the brain: advantages and challenges. Pharmaceutics
2022;14:672. DOI PubMed PMC
191. Liang G, Kan S, Zhu Y, Feng S, Feng W, Gao S. Engineered exosome-mediated delivery of functionally active miR-26a and its
enhanced suppression effect in HepG2 cells. Int J Nanomedicine 2018;13:585-99. DOI PubMed PMC
192. Wang JH, Forterre AV, Zhao J, et al. Anti-HER2 scFv-directed extracellular vesicle-mediated mRNA-based gene delivery inhibits
growth of HER2-positive human breast tumor xenografts by prodrug activation. Mol Cancer Ther 2018;17:1133-42. DOI
193. Kooijmans SA, Aleza CG, Roffler SR, van Solinge WW, Vader P, Schiffelers RM. Display of GPI-anchored anti-EGFR nanobodies
on extracellular vesicles promotes tumour cell targeting. J Extracell Vesicles 2016;5:31053. DOI PubMed PMC
194. Ohno S, Takanashi M, Sudo K, et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer
cells. Mol Ther 2013;21:185-91. DOI PubMed PMC
195. Choi H, Choi Y, Yim HY, Mirzaaghasi A, Yoo JK, Choi C. Biodistribution of Exosomes and Engineering Strategies for Targeted
Delivery of Therapeutic Exosomes. Tissue Eng Regen Med 2021;18:499-511. DOI PubMed PMC
196. Rivoltini L, Chiodoni C, Squarcina P, et al. TNF-related apoptosis-inducing ligand (TRAIL)-armed exosomes deliver proapoptotic
signals to tumor site. Clin Cancer Res 2016;22:3499-512. DOI
197. Zheng W, He R, Liang X, et al. Cell-specific targeting of extracellular vesicles though engineering the glycocalyx. J Extracell
Vesicles 2022;11:e12290. DOI PubMed PMC
198. Richter M, Vader P, Fuhrmann G. Approaches to surface engineering of extracellular vesicles. Adv Drug Deliv Rev 2021;173:416-26.
DOI PubMed
199. Tian T, Zhang HX, He CP, et al. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy.
Biomaterials 2018;150:137-49. DOI
200. Jia G, Han Y, An Y, et al. NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro
and in vivo. Biomaterials 2018;178:302-16. DOI
201. Wang Y, Chen X, Tian B, et al. Nucleolin-targeted extracellular vesicles as a versatile platform for biologics delivery to breast
cancer. Theranostics 2017;7:1360-72. DOI PubMed PMC
202. Pi F, Binzel DW, Lee TJ, et al. Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for
cancer regression. Nat Nanotechnol 2018;13:82-9. DOI PubMed PMC
203. Li L, He D, Guo Q, et al. Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes
chemoresistant ovarian cancer. J Nanobiotechnology 2022;20:50. DOI PubMed PMC